Qodebook Right Code · Any Purpose

Lonazolac

Commodity a leaf — nothing below it, 9 links to KBLI

Level
Commodity
Parent
51384600
Below
0
Links · KBLI
9

Definition

UNSPSC 51384613

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H13ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 13097143QI, chemically known as 1h-pyrazole-4-acetic acid, 3-(4-chlorophenyl)-1-phenyl- but generally known as lonazolac, which bears US NIH Compound Identifier 68706. European Medicines Agency schedules Lonazolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08570MIG. The term LONAZOLAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules lonazolac in its Anatomical Therapeutic Chemical (ATC) Classification. LONAZOLAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lonazolac under HS 29331990 and SITC 51571. As of Q4 2014, LONAZOLAC remains the US FDA Preferred Term for this commodity. Lonazolac bears US NLM identifiers UMLS ID C0065166 and NCI Concept Code C66031. SMILES: CLC1CCC(C2NN(CC2CC(=O)O)C2CCCCC2)CC1.

Same parent

Under 51384600 · 33
51384601 Dipyrone or metamizol or metamizole Commodity 51384602 Aminophenazone or aminopyrine Commodity 51384603 Antipyrine or phenazone or phenazon or analgesine Commodity 51384604 Bendazac or bendazolic acid Commodity 51384605 Benzydamine Commodity 51384606 Bisfenazone Commodity 51384607 Celecoxib Commodity 51384608 Difenamizole Commodity 51384609 Oxyphenbutazone Commodity 51384610 Edaravone or norphenazone Commodity 51384611 Feprazone Commodity 51384612 Kebuzone or ketophenylbutazone Commodity 51384613 Lonazolac You are here 51384614 Mofebutazone Commodity 51384615 Niprofazone Commodity 51384616 Pirazolac Commodity 51384617 Propyphenazone Commodity 51384618 Suxibuzone Commodity 51384619 Trifezolac Commodity 51384620 Phenylbutazone Commodity 51384621 Aminophenazone cyclamate Commodity 51384622 Praxadine Commodity 51384623 Bendazac lysine dihydrate Commodity 51384624 Bendazac sodium Commodity 51384625 Benzydamine hydrochloride Commodity 51384626 Lonazolac calcium Commodity 51384627 Metamizole sodium Commodity 51384628 Mofebutazone sodium Commodity 51384629 Oxyphenbutazone anhydrous Commodity 51384630 Oxyphenbutazone piperazine Commodity 51384631 Phenazone salicylate Commodity 51384632 Phenylbutazone calcium Commodity 51384633 Phenylbutazone sodium Commodity

Activities that produce or sell this

KBLI · 9

Inherited from family 51380000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47111 Perdagangan Eceran Berbagai Macam Barang yang Utamanya Makanan, Minuman, atau Tembakau dengan Sistem Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class

Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.